Next-Generation Biomarker Measurement

An innovative point-of-care testing platform, delivering lab‑grade results within 5 minutes, from a single drop of capillary blood.

Results within

5minutes

Limit of detection

0.5ng/L for cTnI

From a single drop

50µL sample

Multiplexing across

5cardiac biomarkers

Macro of a dark tropical leaf whose veins converge at the base and resolve into the gold and black traces of a biosensor electrode array, with a single water droplet on the leaf surface

Innovation

Lab-grade sensitivity at point of care

Spectants' B2X point-of-care platform turns a 50 µL sample of capillary blood into an actionable result in minutes.

A single‑use cartridge collects a finger‑prick sample and docks into a handheld reader, delivering laboratory‑grade biomarker measurement.

More about our technology

A scientist in a white lab coat before a tall doorway of red light, at the threshold of a breakthrough

The Challenge

Time = Life

In emergency medicine, triage decisions depend on accurate biomarker measurements.

Centralized laboratories impose delays of 1 to 24 hours on critical biomarker tests, which have direct consequences for patients and for medical staff.

Learn how we do it

A doctor in a white coat talking with an older patient at the foot of a sculptural white spiral staircase in a bright panelled hall; a nurse walks down the stairs, and to the right a narrow door beneath a green emergency-exit sign stands slightly ajar

Mission

Rule in. Rule out. Reduce costs.

Faster, more accurate biomarker measurement at point of care changes the equation of acute medicine:

Ruling in to reduce mortality in patients who need urgent care.
Ruling out to safely discharge low‑risk patients.
Reducing costs through fewer admissions, transfers and delays in healthcare.

See our vision

Ready for more?

Get in touch Explore the Technology